NCT03451448Completed
PET MRI in Coronary Artery Disease
Combined Magnetic Resonance Coronary Angiography and Positron Emission Tomography in Patients With Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 21 May 2024
Brief summary (registry, in English)
This study will assess the use of position emission tomography/magnetic resonance imaging (PET/MRI) using ultra-small-superparamagnetic particles of iron oxide (USPIO) as a contrast agent in patients with coronary artery disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 16 (actual)
- First submitted
- 23 Feb 2018
- Start date
- 1 Feb 2018
- Primary completion date
- 1 May 2023
- Lead sponsor
- University of Edinburgh
- Diseases
- Coronary artery disease
- NCT number
- NCT03451448
What you commit to
- Study type: Observational
- Participants enrolled: 16
- From 1 Feb 2018 to the primary completion date, 1 May 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- hepatic failure
- contraindications to contrast agents not included above including evidence of iron overload, known allergy to constituents of the contrast agents, and anaemia not caused by iron deficiency
Lab values
- renal failure (Serum creatinine \>200 umol/L or estimated glomerular filtration rate \<30 mL/min
Other
- inability or unwillingness to undergo magnetic resonance imaging or positron emission tomography
- pregnancy
- inability to provide informed consent
- contraindications to undergoing MRI scanning
Who the study is looking for
- Healthy volunteers to undergo MRI imaging will be over the age of 18 years and able to provide informed consent.
- Patients with coronary artery disease to undergo PET/MRI will have multi-vessel disease (≥2 vessel coronary artery disease with ≥ 50% cross-sectional luminal stenosis).
- able to provide informed consent
- over the age of 40 years
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Infirmary of Edinburgh Coordinator of this site? Confirm its status | Edinburgh | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.